FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Nephron Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for albuterol sulfate submitted by Nephron Pharmaceuticals Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchospasm
• Chronic Obstructive Pulmonary Disease
• Exercise-induced Bronchospasm

Drugs mentioned

• Albuterol sulfate (generic) (albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE (ALBUTEROL SULFATE)